Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
are reviewed on a rolling basis. We will give preference to applications received by 30 March 2026, but will continue reviewing until the position is filled. For more information about the DPZ, please visit http
-
of record, motivation letter) by March 8th, 2026. Please send it via our online applications system (single pdf file, less then 5 MB) https://www.leibniz-inm.de/en/job-offers-2/ For further information
-
of crossing protocols for hybridization. Cytogenetic analysis of Bulbosum and barley. Generate and analyze whole genome sequencing data. Analysis, publication, and presentation of research results. Become a
-
to gain further qualifications. We offer our employees a broad spectrum of career opportunities in an attractive working professional environment (https://www.dwi.rwthaachen.de/seite/institutskultur). DWI
-
its employees in reconciling work and family life and regularly undergoes the audit berufundfamilie® . Further information at: http://www.ifw-dresden.de . The Institute for Emerging Electronic
-
its employees in reconciling work and family life and regularly undergoes the audit berufundfamilie® . Further information at: http://www.ifw-dresden.de . The Institute for Materials Chemistry, Group
-
processes the personal data of its applicants in accordance with European and German legal regulations. Further information on data protection and the processing of personal data can be found at: https
-
to the privacy policy on our homepage at https://www.senckenberg.de/en/imprint/ With the submission of your application, you consent to your personal data being shared with an external member of
-
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (https://lit.eu ) – is a biomedical research center focusing on translational immunology in the fields of cancer
-
. Applications arriving until January 4th . 2026 are considered for this position. For more information about the DPZ, please visit http://www.dpz.eu or call 0551 / 3851-105.